anmelden
SLI
2.318,31
PKT
-8,99
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.02.24 | UBS Buy | Deutsche Bank AG | |
| 21.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 20.02.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.02.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | Swiss Re Hold | Deutsche Bank AG | |
| 19.02.24 | Swiss Re Sell | UBS AG | |
| 17.02.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 16.02.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 16.02.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.02.24 | Swiss Re Halten | DZ BANK | |
| 16.02.24 | Swiss Re Sell | UBS AG | |
| 16.02.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 16.02.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 16.02.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 14.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 13.02.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 12.02.24 | Nestlé Add | Baader Bank | |
| 12.02.24 | Nestlé Market-Perform | Bernstein Research | |
| 12.02.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.24 | Swiss Re Equal Weight | Barclays Capital | |
| 09.02.24 | UBS Underweight | Barclays Capital | |
| 08.02.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.02.24 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 07.02.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | UBS Buy | Deutsche Bank AG | |
| 07.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | UBS Outperform | RBC Capital Markets | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Underweight | Barclays Capital | |
| 06.02.24 | UBS Underweight | Barclays Capital | |
| 06.02.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Roche Sell | Deutsche Bank AG | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 05.02.24 | Roche Neutral | UBS AG |
